Read the latest about us
I was curious to interview Christina Herder, the CEO of Modus Therapeutics, which launched a Phase II trial in co-operation with Bahrain and the rest of the Emirates.
Modus Therapeutics AB announced Feb. 16, the Middle East University has shouldered some of the risk of developing sevuparin.
Sankt Eriksgatan 117,
SE-113 43 Stockholm, Sweden
+46 70 374 71 56
© 2017 Modus Therapeutics | All Rights Reserved